Role of Posttranslational Modifications of Proteins in Cardiovascular Disease.

Yong-Ping Liu, Tie-Ning Zhang, Ri Wen, Chun-Feng Liu, Ni Yang

Oxidative medicine and cellular longevity 2022

filter terms:

Cardiovascular disease (CVD) has become a leading cause of mortality and morbidity globally, making it an urgent concern. Although some studies have been performed on CVD, its molecular mechanism remains largely unknown for all types of CVD. However, recent in vivo and in vitro studies have successfully identified the important roles of posttranslational modifications (PTMs) in various diseases, including CVD. Protein modification, also known as PTMs, refers to the chemical modification of specific amino acid residues after protein biosynthesis, which is a key process that can influence the activity or expression level of proteins. Studies on PTMs have contributed directly to improving the therapeutic strategies for CVD. In this review, we examined recent progress on PTMs and highlighted their importance in both physiological and pathological conditions of the cardiovascular system. Overall, the findings of this review contribute to the understanding of PTMs and their potential roles in the treatment of CVD. Copyright © 2022 Yong-Ping Liu et al.

Citation

Yong-Ping Liu, Tie-Ning Zhang, Ri Wen, Chun-Feng Liu, Ni Yang. Role of Posttranslational Modifications of Proteins in Cardiovascular Disease. Oxidative medicine and cellular longevity. 2022;2022:3137329